This is a community-generated profile. If you would like to claim it, please .
Illumina
Develops tools for DNA, RNA, and protein analysis for disease research5000+ EmployeesActively Hiring
Illumina Funding
$500M
11 round
Illumina is active in the following markets / industries: B2B and professional services. The company has secured funding across 1 rounds, totaling in an amount of $500M. Their most recent funding was raised on September 6, 2024.
Funding Rounds
S
$500000000Investors of Illumina
A recognized expert in the planning and design of educational facilities. His practice experience delineate strategies for future change and growth.
Kyle Hernandez, Ph.D.
I am a quantitative genetics and bioinformatics research professional with a strong statistical and computational background.
Blockchain specialist. Venture capitalist, hedge fund manager, technology executive. Princeton University.
Brad Stephens is a Founder and Managing Partner of Blockchain Capital LLC
Acquisitions of Illumina
Nextbio
Exit
